Surgery Partners (SGRY) Cash from Financing Activities (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Cash from Financing Activities data on file, last reported at -$55.9 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 285.1% year-over-year to -$55.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$143.4 million (down 155.05% YoY) and the FY2025 annual result came in at -$57.3 million, down 121.87% from the prior year.
• Cash from Financing Activities slipped to -$55.9 million in Q1 2026 per SGRY's latest filing, from $59.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $193.1 million in Q4 2022, with the low at -$84.1 million in Q3 2025.
• Average Cash from Financing Activities over 5 years is $2.1 million, with a median of -$41.2 million recorded in 2023.
• Year-over-year, Cash from Financing Activities soared 486.94% in 2024 and sank 1052.05% in 2025.
• Surgery Partners' Cash from Financing Activities stood at $193.1 million in 2022, then tumbled by 123.1% to -$44.6 million in 2023, then jumped by 207.62% to $48.0 million in 2024, then rose by 23.33% to $59.2 million in 2025, then tumbled by 194.43% to -$55.9 million in 2026.
• Business Quant data shows SGRY's Cash from Financing Activities at -$55.9 million in Q1 2026, $59.2 million in Q4 2025, and -$84.1 million in Q3 2025.